Related Experiment Videos
Dipyridamole stress echocardiography.
1National Research Council, Institute of Clinical Physiology, Pisa, Italy. picano@ifc.pi.cnr.it
Cardiology Clinics
|August 24, 1999
Summary
Dipyridamole stress echocardiography is a safe and effective tool for diagnosing coronary artery disease, offering valuable prognostic information. Its diagnostic accuracy is comparable to other methods and depends on dosage.
Area of Science:
- Cardiology
- Diagnostic Imaging
Background:
- Dipyridamole stress echocardiography is a foundational pharmacological stress test for diagnosing coronary artery disease (CAD).
- Extensive multicenter studies have confirmed its safety profile.
Purpose of the Study:
- To evaluate the diagnostic accuracy and prognostic value of dipyridamole stress echocardiography in CAD.
- To compare its efficacy with other stress testing modalities.
Main Methods:
- Utilized dipyridamole infusion up to 0.84 mg/kg to induce myocardial stress.
- Assessed diagnostic accuracy and prognostic value by correlating echocardiographic findings with clinical, exercise echocardiogram, and angiographic data.
- Titrated positive test response based on induced dyssynergy severity, extent, and timing.
Main Results:
- Diagnostic accuracy is comparable to dobutamine stress echocardiography, influenced by drug dosage.
- Higher dipyridamole doses (up to 0.84 mg/kg) enhance sensitivity.
- Prognostic value is independent and additive to other diagnostic data.
- Low positivity indicates more severe anatomical and functional disease.
Conclusions:
- Dipyridamole stress echocardiography is a reliable diagnostic and prognostic tool for CAD.
- Ongoing studies are investigating its cost-effectiveness against invasive strategies like coronary angiography.